Valid Assessment of Long-Term Effects of Mefloquine Requires Measurement of Symptomatic Exposure

Mil Med. 2023 Nov 3;188(11-12):310-311. doi: 10.1093/milmed/usad236.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antimalarials* / adverse effects
  • Cohort Studies
  • Cross-Sectional Studies
  • Humans
  • Mefloquine / adverse effects
  • Veterans*

Substances

  • Mefloquine
  • Antimalarials